Top Markets
Coin of the day
Runben Biotechnology Runben Biotechnology

Runben Biotechnology

603193
Rank in Stocks #8639
Runben Biotechnology Co., Ltd. focuses on the creation, production, and... Runben Biotechnology Co., Ltd. focuses on the creation, production, and distribution of mosquito repellent solutions, infant care items, and essential oil products. The company primarily sells its offerings through digital sales channels. Established in 2013, Runben Biotechnology is headquartered in Guangzhou, China, and functions as a division of Guangzhou Zhuofan Investment Holding Co., Ltd.
Share Price
$2.98
Last synced: 2026-08-28
Market Cap
$1.20B
Change (1 day)
0.05%
Change (1 year)
-28.50%
Country
CN
Trade Runben Biotechnology (603193)
P/E ratio for Runben Biotechnology (603193)
P/E ratio as of 2026 TTM: 0
According to Runben Biotechnology latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Runben Biotechnology from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
21.41 -
US
32.48 -
FR
36.14 -
US
32.63 -
IN
-126.62 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.